Roche's Lucentis Could Get Boost From House Compounding Directives To FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Compounding pharmacies – and makers of particular products – would see favorable guidance changes under instructions to FDA in House appropriations report.